Zobrazeno 1 - 3
of 3
pro vyhledávání: '"John F. Thompson, MD"'
Autor:
Licata Gaetano, MD, Birra Domenico, MD, Serigne N. Lo, PhD, Tasnia Hamed, MS, Alison J. Potter, MD, John F. Thompson, MD, Richard A. Scolyer, MD, Pascale Guitera, MD, PhD
Publikováno v:
JAAD International, Vol 8, Iss , Pp 102-108 (2022)
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the risk of recurrence is lacking. Objective: To identify clinicopathological predictors of local recurrence (LR) in patients with MIS and evaluate long-term
Externí odkaz:
https://doaj.org/article/e58f7eb4f49e4686ba72ad9c7bd56716
Autor:
Moncrieff MD; Marc D. Moncrieff, MD, Norfolk & Norwich University Hospital, Norwich, United Kingdom; Vernon K. Sondak, MD, H. Lee Moffitt Cancer Center, Tampa, FL; John F. Thompson, MD, Melanoma Institute Australia, Sydney, New South Wales, Australia; and Jonathan S. Zager, MD, H. Lee Moffitt Cancer Center, Tampa, FL., Sondak VK; Marc D. Moncrieff, MD, Norfolk & Norwich University Hospital, Norwich, United Kingdom; Vernon K. Sondak, MD, H. Lee Moffitt Cancer Center, Tampa, FL; John F. Thompson, MD, Melanoma Institute Australia, Sydney, New South Wales, Australia; and Jonathan S. Zager, MD, H. Lee Moffitt Cancer Center, Tampa, FL., Thompson JF; Marc D. Moncrieff, MD, Norfolk & Norwich University Hospital, Norwich, United Kingdom; Vernon K. Sondak, MD, H. Lee Moffitt Cancer Center, Tampa, FL; John F. Thompson, MD, Melanoma Institute Australia, Sydney, New South Wales, Australia; and Jonathan S. Zager, MD, H. Lee Moffitt Cancer Center, Tampa, FL., Zager JS; Marc D. Moncrieff, MD, Norfolk & Norwich University Hospital, Norwich, United Kingdom; Vernon K. Sondak, MD, H. Lee Moffitt Cancer Center, Tampa, FL; John F. Thompson, MD, Melanoma Institute Australia, Sydney, New South Wales, Australia; and Jonathan S. Zager, MD, H. Lee Moffitt Cancer Center, Tampa, FL.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Feb 20; Vol. 41 (6), pp. 1326-1327. Date of Electronic Publication: 2022 Dec 01.
Autor:
Varey AHR; Alexander H. R. Varey, MBChB, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Plastic Surgery, Westmead Hospital, Westmead, NSW, Australia; Serigne N. Lo, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Richard A. Scolyer, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Tissue Oncology and Diagnostic Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Camperdown, NSW, Australia; and John F. Thompson, MD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Lo SN; Alexander H. R. Varey, MBChB, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Plastic Surgery, Westmead Hospital, Westmead, NSW, Australia; Serigne N. Lo, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Richard A. Scolyer, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Tissue Oncology and Diagnostic Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Camperdown, NSW, Australia; and John F. Thompson, MD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Scolyer RA; Alexander H. R. Varey, MBChB, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Plastic Surgery, Westmead Hospital, Westmead, NSW, Australia; Serigne N. Lo, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Richard A. Scolyer, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Tissue Oncology and Diagnostic Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Camperdown, NSW, Australia; and John F. Thompson, MD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Thompson JF; Alexander H. R. Varey, MBChB, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Plastic Surgery, Westmead Hospital, Westmead, NSW, Australia; Serigne N. Lo, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Richard A. Scolyer, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Tissue Oncology and Diagnostic Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Camperdown, NSW, Australia; and John F. Thompson, MD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2020 Nov; Vol. 4, pp. 990-991.